哥只是传说888
2021-02-16
Buy cresco labs or curaleaf!
Here are analysts’ favorite marijuana stocks, which they expect to rise as much as 82% in the next year
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":382828829,"tweetId":"382828829","gmtCreate":1613432270761,"gmtModify":1634553723402,"author":{"id":3573197498765799,"idStr":"3573197498765799","authorId":3573197498765799,"authorIdStr":"3573197498765799","name":"哥只是传说888","avatar":"https://static.tigerbbs.com/089a79c967332e71a399e08f5edc192e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Buy cresco labs or curaleaf!</p></body></html>","htmlText":"<html><head></head><body><p>Buy cresco labs or curaleaf!</p></body></html>","text":"Buy cresco labs or curaleaf!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/382828829","repostId":1106106453,"repostType":4,"repost":{"id":"1106106453","pubTimestamp":1612929529,"share":"https://www.laohu8.com/m/news/1106106453?lang=&edition=full","pubTime":"2021-02-10 11:58","market":"us","language":"en","title":"Here are analysts’ favorite marijuana stocks, which they expect to rise as much as 82% in the next year","url":"https://stock-news.laohu8.com/highlight/detail?id=1106106453","media":"MarketWatch","summary":"Legalization is spreading across the U.S.\nMarijuana stocks have surged this year as investors antici","content":"<p>Legalization is spreading across the U.S.</p>\n<p>Marijuana stocks have surged this year as investors anticipate wider acceptance of legal distribution of recreational products in the U.S.</p>\n<p>Your best way to ride this wave may be through exchange traded funds. But investors also like to see lists of stocks in rapidly growing industries.</p>\n<p>So, below, is a list of analysts’ favorite stocks associated with the increased use of cannabis, drawn from holdings of six of the largest ETFs tracking the industry.</p>\n<p>For broad coverage of the rapidly expanding marijuana industry, see Cannabis Watch. Recent coverage includes efforts by Senate Majority Leader Chuck Schumer to introduce legislation for the federal legalization of marijuana and New York Gov. Andrew Cuomo’s drive toward legalization in his state.</p>\n<p>To see how dramatic the stock market reaction has been, take a look at this chart for the ETFMG Alternative Harvest ETFMJ,+13.42%,the largest exchange traded fund in the space:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/966a21e7913c10dbe106b6dcb5b54abc\" tg-width=\"1259\" tg-height=\"1172\"><span>FACTSET</span></p>\n<p>Of note: That’s a year-to-date chart through 2:34 p.m. ET on Feb. 9. The ETF has doubled so far in 2021. During 2020, it fell 12%.</p>\n<p>For an example of the heated action, shares of Canopy Growth Corp. were up as much as 12% in morning trading on Feb. 9, after the company announced higher-than-expected salesfor the quarter ended Dec. 31.</p>\n<p><b>Marijuana stock list</b></p>\n<p>In order to come up with a list of analysts’ favorite marijuana-associated stocks, we collated the holdings of six of the largest marijuana ETFs:</p>\n<ul>\n <li>The ETFMG Alternative Harvest ETF has $1.8 billion in assets under management and annual expenses of 0.75% of assets. The ETF holds 30 stocks and is heavily concentrated, with Tilray Inc.,making up 13.7% of the portfolio and Aphria Inc. accounting for 13.4%. According to ETFMG, the ETF is designed to “measure the performance of companies within the cannabis ecosystem benefitting from global medicinal and recreational cannabis legalization initiatives.” This broad objective means it holds shares of several large tobacco companies: Philip Morris International Inc.Altria Group Inc. and British American Tobacco.</li>\n <li>The AdvisorShares Pure US Cannabis ETF has $604 million in assets and annual expenses of 0.74%. AdvisorShares bills this ETF as the only one that is both actively managed and U.S.-focused.</li>\n <li>The Horizons Marijuana Life Sciences Index ETF has $583 million in assets and an expense ratio of 0.94%.</li>\n <li>The AdvisorShares Pure Cannabis ETF has $323 million in assets, with an annual expense ratio of 0.75%. It invests in companies that derive at least 50% of revenue from the cannabis industry, but may also invest in pre-revenue companies doing research and development on marijuana-derived products.</li>\n <li>The Global X Cannabis ETFPOTX,+17.23%has $149 million in assets with an expense ratio of 0.50%. It has a highly concentrated portfolio of 18 stocks, with Tilray making up 16.9% of the portfolio, Aphria 11.9% and Aurora Cannabis Inc. 10.2%.</li>\n <li>The Cannabis ETF has $117 million in assets with annual expenses of 0.70%. The ETF holds a broad group of 29 U.S. and Canadian marijuana stocks.</li>\n</ul>\n<p>The only stock held by all six ETFs is Charlotte’s Web Holdings Inc..The company is based in Boulder, Colo., but all six ETFs hold shares traded under its Canadian ticker, CWEB.</p>\n<p>Analysts favorite marijuana stocks</p>\n<p>The six ETFs listed above hold 85 stocks or total return swaps tied to the stocks. A few of these companies are “double counted,” with one or more ETFs holding shares traded in Canada and one or more holding the shares traded on U.S. exchanges. In the table below, the tickers without an exchange code before them, are U.S. tickers.</p>\n<p>The list includes countries where the companies are based. The share prices and price targets are in local currencies. Tobacco companies are not excluded, because the managers of the ETFMG Alternative Harvest ETF (at least) believe they will benefit from the expanding regulatory acceptance of recreational marijuana use.</p>\n<p>Among the 85 stocks, 28 have majority “buy” or equivalent ratings among analysts polled by FactSet, with at least five analysts covering each company. Some of these stocks have gotten ahead of consensus price targets.</p>\n<p>Here they are, sorted by the 12-month upside potential implied by consensus price targets:</p>\n<p></p>\n<table>\n <thead>\n <tr>\n <th>COMPANY</th>\n <th>TICKER</th>\n <th>COUNTRY</th>\n <th>SHARE 'BUY' RATINGS</th>\n <th>CLOSING PRICE - FEB. 8</th>\n <th>CONSENSUS PRICE TARGET</th>\n <th>IMPLIED 12-MONTH UPSIDE POTENTIAL</th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td>VALENS CO. INC.</td>\n <td>TO:VLNS</td>\n <td>CANADA</td>\n <td>89%</td>\n <td>1.96</td>\n <td>3.57</td>\n <td>82%</td>\n </tr>\n <tr>\n <td>Cara Therapeutics Inc.</td>\n <td>CARA</td>\n <td>U.S.</td>\n <td>88%</td>\n <td>19.46</td>\n <td>33.50</td>\n <td>72%</td>\n </tr>\n <tr>\n <td>MediPharm Labs Corp.</td>\n <td>TO:LABS</td>\n <td>Canada</td>\n <td>60%</td>\n <td>0.76</td>\n <td>1.29</td>\n <td>70%</td>\n </tr>\n <tr>\n <td>British American Tobacco PLC</td>\n <td>UK:BATS</td>\n <td>U.K.</td>\n <td>84%</td>\n <td>26.96</td>\n <td>36.74</td>\n <td>36%</td>\n </tr>\n <tr>\n <td>Imperial Brands PLC</td>\n <td>UK:IMB</td>\n <td>U.K.</td>\n <td>74%</td>\n <td>14.43</td>\n <td>19.32</td>\n <td>34%</td>\n </tr>\n <tr>\n <td>AYR Strategies Inc.</td>\n <td>AYRWF</td>\n <td>U.S.</td>\n <td>88%</td>\n <td>34.45</td>\n <td>44.99</td>\n <td>31%</td>\n </tr>\n <tr>\n <td>Zynerba Pharmaceuticals Inc.</td>\n <td>ZYNE</td>\n <td>U.S.</td>\n <td>71%</td>\n <td>5.74</td>\n <td>7.42</td>\n <td>29%</td>\n </tr>\n <tr>\n <td>Village Farms International Inc.</td>\n <td>TO:VFF</td>\n <td>Canada</td>\n <td>100%</td>\n <td>21.07</td>\n <td>27.17</td>\n <td>29%</td>\n </tr>\n <tr>\n <td>Columbia Care Inc.</td>\n <td>CCHWF</td>\n <td>U.S.</td>\n <td>83%</td>\n <td>7.57</td>\n <td>9.65</td>\n <td>27%</td>\n </tr>\n <tr>\n <td>Arena Pharmaceuticals Inc.</td>\n <td>ARNA</td>\n <td>U.S.</td>\n <td>100%</td>\n <td>81.97</td>\n <td>95.20</td>\n <td>16%</td>\n </tr>\n <tr>\n <td>Altria Group Inc.</td>\n <td>MO</td>\n <td>U.S.</td>\n <td>67%</td>\n <td>42.97</td>\n <td>49.00</td>\n <td>14%</td>\n </tr>\n <tr>\n <td>Jushi Holdings Inc. Class B</td>\n <td>JUSHF</td>\n <td>U.S.</td>\n <td>83%</td>\n <td>8.49</td>\n <td>9.68</td>\n <td>14%</td>\n </tr>\n <tr>\n <td>Swedish Match AB</td>\n <td>SE:SWMA</td>\n <td>Sweden</td>\n <td>76%</td>\n <td>667.40</td>\n <td>754.88</td>\n <td>13%</td>\n </tr>\n <tr>\n <td>Scotts Miracle-Gro Co. Class A</td>\n <td>SMG</td>\n <td>U.S.</td>\n <td>71%</td>\n <td>239.52</td>\n <td>266.40</td>\n <td>11%</td>\n </tr>\n <tr>\n <td>Philip Morris International Inc.</td>\n <td>PM</td>\n <td>U.S.</td>\n <td>70%</td>\n <td>85.99</td>\n <td>95.20</td>\n <td>11%</td>\n </tr>\n <tr>\n <td>Curaleaf Holdings Inc.</td>\n <td>CURLF</td>\n <td>U.S.</td>\n <td>93%</td>\n <td>16.73</td>\n <td>17.89</td>\n <td>7%</td>\n </tr>\n <tr>\n <td>Trulieve Cannabis Corp.</td>\n <td>TCNNF</td>\n <td>U.S.</td>\n <td>100%</td>\n <td>49.49</td>\n <td>51.33</td>\n <td>4%</td>\n </tr>\n <tr>\n <td>Cresco Labs Inc.</td>\n <td>CRLBF</td>\n <td>U.S.</td>\n <td>93%</td>\n <td>15.57</td>\n <td>15.97</td>\n <td>3%</td>\n </tr>\n <tr>\n <td>Charlotte's Web Holdings Inc.</td>\n <td>TO:APHA</td>\n <td>U.S.</td>\n <td>75%</td>\n <td>6.87</td>\n <td>6.88</td>\n <td>0%</td>\n </tr>\n <tr>\n <td>Harvest Health & Recreation Inc.</td>\n <td>HRVSF</td>\n <td>U.S.</td>\n <td>86%</td>\n <td>4.02</td>\n <td>3.88</td>\n <td>-4%</td>\n </tr>\n <tr>\n <td>Innovative Industrial Properties Inc.</td>\n <td>IIPR</td>\n <td>U.S.</td>\n <td>71%</td>\n <td>215.18</td>\n <td>207.17</td>\n <td>-4%</td>\n </tr>\n <tr>\n <td>Turning Point Brands Inc.</td>\n <td>TPB</td>\n <td>U.S.</td>\n <td>100%</td>\n <td>55.74</td>\n <td>53.60</td>\n <td>-4%</td>\n </tr>\n <tr>\n <td>Green Thumb Industries Inc.</td>\n <td>GTBIF</td>\n <td>U.S.</td>\n <td>94%</td>\n <td>33.90</td>\n <td>32.48</td>\n <td>-4%</td>\n </tr>\n <tr>\n <td>Greenlane Holdings Inc. Class A</td>\n <td>GNLN</td>\n <td>U.S.</td>\n <td>100%</td>\n <td>5.97</td>\n <td>5.40</td>\n <td>-10%</td>\n </tr>\n <tr>\n <td>TerrAscend Corp.</td>\n <td>TRSSF</td>\n <td>Canada</td>\n <td>100%</td>\n <td>14.88</td>\n <td>12.75</td>\n <td>-14%</td>\n </tr>\n <tr>\n <td>GrowGeneration Corp.</td>\n <td>GRWG</td>\n <td>U.S.</td>\n <td>57%</td>\n <td>62.97</td>\n <td>52.71</td>\n <td>-16%</td>\n </tr>\n <tr>\n <td>Hydrofarm Holdings Group Inc.</td>\n <td>HYFM</td>\n <td>U.S.</td>\n <td>100%</td>\n <td>80.48</td>\n <td>63.25</td>\n <td>-21%</td>\n </tr>\n <tr>\n <td>Aphria Inc.</td>\n <td>TO:APHA</td>\n <td>Canada</td>\n <td>64%</td>\n <td>24.16</td>\n <td>15.98</td>\n <td>-34%</td>\n </tr>\n </tbody>\n</table>\n<p>FactSet</p>\n<p>If you see any stocks of interest, it is best to do your own research to learn how a company is planning to grow and compete. The ETFs provide the advantage of diversification. Selecting individual stocks may turn out well, but buyer beware.</p>\n<p>Among the larger holdings of the ETFs, Tilray was not included in the list because only 14% of analysts polled by FactSet rate the shares a buy. None of the 13 analysts covering Aurora Cannabis rate the stock a buy.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here are analysts’ favorite marijuana stocks, which they expect to rise as much as 82% in the next year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere are analysts’ favorite marijuana stocks, which they expect to rise as much as 82% in the next year\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-10 11:58 GMT+8 <a href=https://www.marketwatch.com/story/here-are-analysts-favorite-marijuana-stocks-which-they-expect-to-rise-as-much-as-82-in-the-next-year-11612892471?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Legalization is spreading across the U.S.\nMarijuana stocks have surged this year as investors anticipate wider acceptance of legal distribution of recreational products in the U.S.\nYour best way to ...</p>\n\n<a href=\"https://www.marketwatch.com/story/here-are-analysts-favorite-marijuana-stocks-which-they-expect-to-rise-as-much-as-82-in-the-next-year-11612892471?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APHA":"Aphria Inc.","AYRWF":"AYR WELLNESS INC.","ARNA":"阿里那","ZYNE":"Zynerba Pharmaceuticals, Inc.","ACB":"奥罗拉大麻公司","JUSHF":"Jushi Holdings Inc.","SNDL":"SNDL Inc.","BATS.UK":"英美烟草公司","DRIO":"DarioHealth","CARA":"Cara Therapeutics, Inc.","MJ":"Amplify Alternative Harvest ETF","VLNSF":"Velan Inc.","TLRY":"Tilray Inc.","CGC":"Canopy Growth Corporation","CRON":"Cronos Group Inc.","MO":"奥驰亚","PM":"菲利普莫里斯","SMG":"Scotts Miracle-Gro Company"},"source_url":"https://www.marketwatch.com/story/here-are-analysts-favorite-marijuana-stocks-which-they-expect-to-rise-as-much-as-82-in-the-next-year-11612892471?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1106106453","content_text":"Legalization is spreading across the U.S.\nMarijuana stocks have surged this year as investors anticipate wider acceptance of legal distribution of recreational products in the U.S.\nYour best way to ride this wave may be through exchange traded funds. But investors also like to see lists of stocks in rapidly growing industries.\nSo, below, is a list of analysts’ favorite stocks associated with the increased use of cannabis, drawn from holdings of six of the largest ETFs tracking the industry.\nFor broad coverage of the rapidly expanding marijuana industry, see Cannabis Watch. Recent coverage includes efforts by Senate Majority Leader Chuck Schumer to introduce legislation for the federal legalization of marijuana and New York Gov. Andrew Cuomo’s drive toward legalization in his state.\nTo see how dramatic the stock market reaction has been, take a look at this chart for the ETFMG Alternative Harvest ETFMJ,+13.42%,the largest exchange traded fund in the space:\nFACTSET\nOf note: That’s a year-to-date chart through 2:34 p.m. ET on Feb. 9. The ETF has doubled so far in 2021. During 2020, it fell 12%.\nFor an example of the heated action, shares of Canopy Growth Corp. were up as much as 12% in morning trading on Feb. 9, after the company announced higher-than-expected salesfor the quarter ended Dec. 31.\nMarijuana stock list\nIn order to come up with a list of analysts’ favorite marijuana-associated stocks, we collated the holdings of six of the largest marijuana ETFs:\n\nThe ETFMG Alternative Harvest ETF has $1.8 billion in assets under management and annual expenses of 0.75% of assets. The ETF holds 30 stocks and is heavily concentrated, with Tilray Inc.,making up 13.7% of the portfolio and Aphria Inc. accounting for 13.4%. According to ETFMG, the ETF is designed to “measure the performance of companies within the cannabis ecosystem benefitting from global medicinal and recreational cannabis legalization initiatives.” This broad objective means it holds shares of several large tobacco companies: Philip Morris International Inc.Altria Group Inc. and British American Tobacco.\nThe AdvisorShares Pure US Cannabis ETF has $604 million in assets and annual expenses of 0.74%. AdvisorShares bills this ETF as the only one that is both actively managed and U.S.-focused.\nThe Horizons Marijuana Life Sciences Index ETF has $583 million in assets and an expense ratio of 0.94%.\nThe AdvisorShares Pure Cannabis ETF has $323 million in assets, with an annual expense ratio of 0.75%. It invests in companies that derive at least 50% of revenue from the cannabis industry, but may also invest in pre-revenue companies doing research and development on marijuana-derived products.\nThe Global X Cannabis ETFPOTX,+17.23%has $149 million in assets with an expense ratio of 0.50%. It has a highly concentrated portfolio of 18 stocks, with Tilray making up 16.9% of the portfolio, Aphria 11.9% and Aurora Cannabis Inc. 10.2%.\nThe Cannabis ETF has $117 million in assets with annual expenses of 0.70%. The ETF holds a broad group of 29 U.S. and Canadian marijuana stocks.\n\nThe only stock held by all six ETFs is Charlotte’s Web Holdings Inc..The company is based in Boulder, Colo., but all six ETFs hold shares traded under its Canadian ticker, CWEB.\nAnalysts favorite marijuana stocks\nThe six ETFs listed above hold 85 stocks or total return swaps tied to the stocks. A few of these companies are “double counted,” with one or more ETFs holding shares traded in Canada and one or more holding the shares traded on U.S. exchanges. In the table below, the tickers without an exchange code before them, are U.S. tickers.\nThe list includes countries where the companies are based. The share prices and price targets are in local currencies. Tobacco companies are not excluded, because the managers of the ETFMG Alternative Harvest ETF (at least) believe they will benefit from the expanding regulatory acceptance of recreational marijuana use.\nAmong the 85 stocks, 28 have majority “buy” or equivalent ratings among analysts polled by FactSet, with at least five analysts covering each company. Some of these stocks have gotten ahead of consensus price targets.\nHere they are, sorted by the 12-month upside potential implied by consensus price targets:\n\n\n\n\nCOMPANY\nTICKER\nCOUNTRY\nSHARE 'BUY' RATINGS\nCLOSING PRICE - FEB. 8\nCONSENSUS PRICE TARGET\nIMPLIED 12-MONTH UPSIDE POTENTIAL\n\n\n\n\nVALENS CO. INC.\nTO:VLNS\nCANADA\n89%\n1.96\n3.57\n82%\n\n\nCara Therapeutics Inc.\nCARA\nU.S.\n88%\n19.46\n33.50\n72%\n\n\nMediPharm Labs Corp.\nTO:LABS\nCanada\n60%\n0.76\n1.29\n70%\n\n\nBritish American Tobacco PLC\nUK:BATS\nU.K.\n84%\n26.96\n36.74\n36%\n\n\nImperial Brands PLC\nUK:IMB\nU.K.\n74%\n14.43\n19.32\n34%\n\n\nAYR Strategies Inc.\nAYRWF\nU.S.\n88%\n34.45\n44.99\n31%\n\n\nZynerba Pharmaceuticals Inc.\nZYNE\nU.S.\n71%\n5.74\n7.42\n29%\n\n\nVillage Farms International Inc.\nTO:VFF\nCanada\n100%\n21.07\n27.17\n29%\n\n\nColumbia Care Inc.\nCCHWF\nU.S.\n83%\n7.57\n9.65\n27%\n\n\nArena Pharmaceuticals Inc.\nARNA\nU.S.\n100%\n81.97\n95.20\n16%\n\n\nAltria Group Inc.\nMO\nU.S.\n67%\n42.97\n49.00\n14%\n\n\nJushi Holdings Inc. Class B\nJUSHF\nU.S.\n83%\n8.49\n9.68\n14%\n\n\nSwedish Match AB\nSE:SWMA\nSweden\n76%\n667.40\n754.88\n13%\n\n\nScotts Miracle-Gro Co. Class A\nSMG\nU.S.\n71%\n239.52\n266.40\n11%\n\n\nPhilip Morris International Inc.\nPM\nU.S.\n70%\n85.99\n95.20\n11%\n\n\nCuraleaf Holdings Inc.\nCURLF\nU.S.\n93%\n16.73\n17.89\n7%\n\n\nTrulieve Cannabis Corp.\nTCNNF\nU.S.\n100%\n49.49\n51.33\n4%\n\n\nCresco Labs Inc.\nCRLBF\nU.S.\n93%\n15.57\n15.97\n3%\n\n\nCharlotte's Web Holdings Inc.\nTO:APHA\nU.S.\n75%\n6.87\n6.88\n0%\n\n\nHarvest Health & Recreation Inc.\nHRVSF\nU.S.\n86%\n4.02\n3.88\n-4%\n\n\nInnovative Industrial Properties Inc.\nIIPR\nU.S.\n71%\n215.18\n207.17\n-4%\n\n\nTurning Point Brands Inc.\nTPB\nU.S.\n100%\n55.74\n53.60\n-4%\n\n\nGreen Thumb Industries Inc.\nGTBIF\nU.S.\n94%\n33.90\n32.48\n-4%\n\n\nGreenlane Holdings Inc. Class A\nGNLN\nU.S.\n100%\n5.97\n5.40\n-10%\n\n\nTerrAscend Corp.\nTRSSF\nCanada\n100%\n14.88\n12.75\n-14%\n\n\nGrowGeneration Corp.\nGRWG\nU.S.\n57%\n62.97\n52.71\n-16%\n\n\nHydrofarm Holdings Group Inc.\nHYFM\nU.S.\n100%\n80.48\n63.25\n-21%\n\n\nAphria Inc.\nTO:APHA\nCanada\n64%\n24.16\n15.98\n-34%\n\n\n\nFactSet\nIf you see any stocks of interest, it is best to do your own research to learn how a company is planning to grow and compete. The ETFs provide the advantage of diversification. Selecting individual stocks may turn out well, but buyer beware.\nAmong the larger holdings of the ETFs, Tilray was not included in the list because only 14% of analysts polled by FactSet rate the shares a buy. None of the 13 analysts covering Aurora Cannabis rate the stock a buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":24,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/382828829"}
精彩评论